BioCentury
ARTICLE | Product Development

COVID-19 update: Sanofi enters vaccine race with BARDA collaboration; plus J&J-BARDA expansion, clinical and diagnostic advances, and more

February 19, 2020 1:09 AM UTC
Updated on Mar 26, 2020 at 1:45 AM UTC

With support from HHS, Sanofi is adapting the platform behind its approved flu vaccine to develop a COVID-19 vaccine.

A Sanofi (Euronext:SAN; NASDAQ:SNY) spokesperson told BioCentury the company will, at its own expense, develop a virus bank and the Biomedical Advanced Research and Development Authority (BARDA) will fund a "research lot that ensures reproducible testing and production of recombinant vaccines." The two will collaborate to choose a COVID-19 strain against which the vaccine will be developed...